Perspective Therapeutics (CATX) Total Non-Current Liabilities (2016 - 2025)

Perspective Therapeutics (CATX) has disclosed Total Non-Current Liabilities for 15 consecutive years, with $59.6 million as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 18.22% to $59.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $59.6 million through Dec 2025, up 18.22% year-over-year, with the annual reading at $59.6 million for FY2025, 18.22% up from the prior year.
  • Total Non-Current Liabilities hit $59.6 million in Q4 2025 for Perspective Therapeutics, up from $52.3 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $62.6 million in Q3 2024 to a low of $2.2 million in Q4 2021.
  • Historically, Total Non-Current Liabilities has averaged $22.8 million across 5 years, with a median of $10.8 million in 2023.
  • Biggest five-year swings in Total Non-Current Liabilities: skyrocketed 713.47% in 2023 and later fell 16.57% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $2.2 million in 2021, then grew by 24.81% to $2.8 million in 2022, then surged by 713.47% to $22.7 million in 2023, then skyrocketed by 121.81% to $50.4 million in 2024, then grew by 18.22% to $59.6 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for CATX at $59.6 million in Q4 2025, $52.3 million in Q3 2025, and $44.7 million in Q2 2025.